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Current translational human studies are moving in the direction of concurrent genomic and proteomic analysis
using small clinical samples. Skin tissue, although easily accessible, is difficult to process owing to its natural
resistance to mechanical shearing and high levels of RNases and proteases. Currently, these complications
result in degraded RNA samples with variable yield. We have developed a method of sequential extraction of
high quality RNA and protein from a single 3 mm full thickness skin punch biopsy. This method yields 1–2 mg of
RNA and 150 mg of protein, which is usable in many sensitive downstream applications including microarray,
quantitative real-time PCR, two-dimensional gel electrophoresis and Western blot analysis.
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INTRODUCTION
There is a substantial research drive to develop human
systems biology. Although much remains to be understood
on how that can be accomplished, it is clear that it will
require RNA and protein from the same human sample for
comparative purposes. Much of the research in translational
human studies is oriented towards using clinical samples that
often require using smaller quantities of tissue per study.
Human skin is easily accessible and therefore obtainable
as a simple clinic biopsy sample. A clinical sample of a full
thickness 3 mm diameter skin punch biopsy addresses the
issue of ease of sample obtainment, with the major drawback
of the biopsy being its limited size and the resilient elastic
nature of skin. Therefore, optimizing processing of these
samples to make the clinical skin biopsy a viable model for
human systems biology is of methodological value.
Skin has evolved to withstand substantial mechanical
stressors and contains high levels of RNases and proteases
which have made it difficult to extract RNA and protein from
these ‘‘tougher’’ samples. Additional complexities in processing
lead to substantial rates of sample loss. A previous
study by Cole et al. (2001b) extracted RNA from breast
skin biopsies, but they were only able to extract usable RNA in
56% of the biopsies. This poor yield was believed to be owing
to degradation of the RNA during the extraction process (Cole
et al., 2001b). Prior methods of a combined RNA and DNA
extraction from 4 mm skin punch biopsies by a different group
had a good yield (50–100 ng of RNA/mg), but again, the quality
of the sample suffered from degradation (Dobbeling et al.,
1997). In other softer tissues, laboratories have been successful
in isolating RNA, DNA, and protein from both lymphocytes
and rat veins (Riol et al., 1999; Rodrigo et al., 2002). Li et al.
(2002) was successful in obtaining RNA, DNA, and hemoglo-
bin from small samples of peripheral blood. It should be noted
that these successful reports all use cells from the blood
compartment where physical disruption of the sample is trivial.
Current techniques and reagents have been developed that
are able to extract RNA, DNA, and protein from the same
sample (Chomczynski, 1993; Li et al., 2002; Rodrigo et al.,
2002). This technique has been successful with the afore-
mentioned blood compartment cells, tissue culture cells,
and softer tissues such as liver and kidney. The typical
recommended method of disruption for tissues and cells is
homogenization, however, ‘‘tough’’ tissue samples, such as
skin, become trapped within the probe, resulting in variable
yields from individual biopsies (http://www.ambion.com/
catalog/CatNum.php?9738; http://www.mrcgene.com/rna.
htm#Description%20of%20TRI%20Reagents; Rodrigo et al.,
2002). Although homogenization is a useful technique for
softer tissues, it is a less than ideal method for processing
small, often irreplaceable, skin biopsy samples.
We have developed a protocol for dual extraction of RNA
and protein, which is optimized for high quantity and quality
and overcomes the technical limitations outlined above.
Skin biopsies from a 3 mm punch, weighing only 19 mg
on average, were sequentially processed for both RNA and
protein. The average yield was 1–2 mg of RNA and 150mg of
protein. This RNA has been successfully used for microarray
experiments and quantitative real-time PCR whereas the
protein has been used for two-dimensional proteomic studies
and Western blot analysis.
RESULTS
Two extraction techniques were used to disrupt the biopsy
samples, homogenization, and bead beating. The instruments
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used were the Kinematica Polytron 1300D homogenizer from
Brinkmann (Westbury, NY) and the FastPreps 120 from
Q-BIOgene (Irvine, CA), respectively. The quantity and
quality of RNA from both extraction techniques were
calculated using a Nanodrop spectrophotometer (Table 1)
(Nanodrop, Wilmington, DE). The average yield of 1.4 mg
RNA with the bead-beating method was 57% higher than
homogenization. The quality of the RNA for both methods
was between 1.8 and 2.1, which is the standard for high
quality RNA (Table 1). To verify the high quality nature of the
RNA for the new technique, we analyzed bead-beater
processed samples with the Agilent 2100 Bioanalyzer
(Agilent, Palo Alto, CA). Typically, RNA quality is determined
by looking at the ratio of ribosomal RNA bands on an agarose
gel. High quality RNA will contain two distinct ribosomal
RNA bands at 28S and 18S and the ratio of these bands will
be about 2.0. The bioanalyzer’s output includes concentra-
tion, the ribosomal ratio, a digital image of RNA quality
showing the 28S and 18S bands, and also an electrophero-
gram showing the overall size of the ribosomal peaks
(Figure 1). Using these data, the bioanalyzer software assigns
a ribosomal integrity number from 1 to 10 to all samples
with 10 being optimal quality. Our samples had ribo-
somal integrity number numbers of between 8.4 and 8.9,
which is consistent with high quality RNA. The algorithm
designed by Agilent is based specifically on characteristics of
RNA, not of nucleic acids in general (Schroeder et al., 2006).
As usual, care must be taken to eliminate phenol
and genomic DNA contamination in RNA preparations. The
2100 Bioanalyzer quantitation is much less susceptible
than spectrophotometer quantitation to these sample con-
taminants. Genomic DNA is easily detected in the electro-
pherogram provided in the analysis. The bioanalyzer will
yield consistent results with phenol contamination up to 5%
(Agilent publication no. 5988-7650EN).
In order to assess whether the RNA was of sufficient
quality for downstream applications we used quantita-
tive real-time PCR to amplify low, medium, and highly
expressed genes. These were: adenosine diphosphate-ribo-
sylation factor 3, cystic fibrosis transmembrane conduc-
tance regulator, zinc finger protein 91, TATA box binding
protein, ornithine decarboxylase-1, and b-actin. Primers
were designed by the second author and manufactured by
Integrated DNA Technologies (Coralville, IA). The specific
primer sequences can be found in the online supple-
mental materials and methods. The Ct value ratios, when
compared to the b-actin control, were between 1 and 1.1.
The Ct values for each of these genes were similar regardless
of method (Table 2).
Protein quantitation was determined using a Coomassie-
based assay using a standard containing bovine serum
albumin in 8 M urea and 10 mM dithiothreitol. The average
yield using the bead-beating technique was 170 mg of protein,
a 53% increase over homogenization (Table 1). The quality
of our extracted protein was assessed by two-dimensional
gel and Western blot analysis. The two-dimensional gel
electrophoresis was performed with 20 mg of protein from
a FastPreps processed biopsy run on an 11 cm pH 3–10
ReadyStrip IPG gel (Bio-Rad, Hercules, CA). The second
dimension was run on a 12.5% polyacrylamide gel which
was silver stained (Figure 2). There was distinct spot
resolution and sufficient protein isolated from a single biopsy
to produce five to six gels.
Western blotting was performed using 12% polyacryla-
mide gels with 10–15 mg of protein from two different
biopsies. Primary antibodies against GADD-45 (growth arrest
Table 1. RNA and protein quantitation
RNA average
quantity per
biopsy (lg)
RNA average
260/280 ratio
Protein average
quantity per
biopsy (lg)
FastPrep bead-beater 1.4 (70.4mg) 2.0 (70.05) 170 (750mg)
Homogenizer 0.8 (70.4mg) 1.8 (70.11) 90 (740mg)
For each method of tissue disruption, the quantity and quality of RNA (as
an OD260/280 ratio), and the quantity of protein is shown. The RNA was
quantified using the Nanodrop spectrophotometer and the protein content
was determined using a Bradford-based assay. For RNA, an OD260/280 of
2.0 is optimal. All quantities are7SD.
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Figure 1. RNA 2100 Bioanalyzer analysis of FastPrep samples. The RNA was
run on an Agilent 2100 Bioanalyzer (Agilent, Palo Alto, CA) using the RNA
6000 Pico LabChip kit to determine the quality of the samples. The 28S
and 18S ribosomal bands show a greater than 2:1 ratio and the calculated
RNA ribosomal integrity numbers of the samples ranged from 8.4 to 8.9
verifying high quality RNA. Shown above are the gel images for 11 RNA
samples and below are two representative electrophoretic graphs showing the
RNA peaks.
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and DNA damage inducible) and cyclin-B1 were used to
probe the membrane (Figure 3). GADD-45 detects both
the alpha and beta portions of the protein, although it is more
sensitive for the alpha portion. Additionally, dot blots were
performed with b-actin to determine the optimal primary and
secondary antibody concentration (data not shown).
DISCUSSION
The challenges of undertaking studies involving human
full thickness skin tissues are diverse. In addition to dealing
with numerous regulatory agencies, the researcher must
obtain samples from consenting patients and overcome
the challenges of working with small, limited biopsies.
Historically, mechanical disruption of skin samples has
been difficult, requiring large amounts of starting tissue
that is ground with a mortar and pestle (Dobbeling et al.,
1997). Although the current trend of homogenization is an
improvement for softer tissues, full thickness skin is naturally
resistant to shearing forces, resulting in incomplete sample
disruption and sample loss.
Although it is possible to separate the dermal and
epidermal layers of a biopsy, a full thickness skin punch
method offers the researcher a human tissue sample with an
intact, three-dimensional architecture that maintains its
physiological cell-to-cell contact and multi-cellular signaling
pathways. Skin contains a multitude of cell types including:
keratinocytes, fibroblasts, melanocytes, Langerhans cells,
nerve fibers, adipocytes, and macrophages, along with
smooth muscle tissue and endothelial cells (Alberts et al.,
2002; Cole et al., 2001a). In many cases, the skin is the
first organ of contact with the environment and the inter-
actions of these layers and cell types are central to the
organismal response to environmental stresses such as
radiation exposure, physical damage, and pathogen attach-
ment. Using the skin punch allows the researcher to take
normal, non-diseased tissue and look for the downstream
effects of these and other environmental stresses.
We tested two suitable physical disruption methods,
homogenizing and bead beating. Full homogenization of
the tissue was difficult to achieve and technically demanding.
Table 2. Gene selection, primer design, and Ct values
for quantitative real-time PCR
Gene – abundance Average Ct value
Ratio of Ct values
compared to b-actin
ARF3 – low 25.9 (70.03)1 1.11
28.7 (70.24)2 1.22
CFTR – low 31.5 (70.06)1 1.41
30.1 (70.02)2 1.32
ZFN91 – medium 26.9 (70.03)1 1.21
26.4 (70.03)2 1.12
TBP – medium 31.9 (70.08)1 1.41
29.4 (70.01)2 1.32
ODC1 – high 27.2 (70.04)1 1.21
28.3 (70.08)2 1.22
b-actin – high 22.9 (70.04)1
23.6 (70.03)2
All of the values for the homogenized and bead-beater samples are similar
indicating that the RNA species distribution is consistent in both
processing methods. See text for full gene names and online Supplemen-
tary material for primer sequences.
The average cycle threshold (Ct) values for each gene using both methods
are presented.
The last column contains the average Ct value for each gene divided by
the Ct average of the control gene, b-actin.
1Fastprep (mean7SD).
2Homogenization (mean7SD).
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Figure 2. Two-dimensional gel electrophoresis. Protein was isolated from a
single 3 mm biopsy using our dual extraction method with the FastPrep bead
beater. Approximately 20 mg of protein was focused on a 11 cm, pH 3–10
ReadyStrip IPG gel (Bio-Rad, Hercules, CA). The second dimension was run
on a 12.5% polyacrylamide gel and the proteins were silver stained.
Cyclin B1
GADD 45
GADD 45
Figure 3. Western blots using biopsy sample protein. Approximately
10–15mg of protein from two different biopsy samples processed with the
FastPrep 120 (Q-BIOgene, Irvine, CA) were used to determine the quality of
Western blotting. The top panel was probed with mouse anti-cyclin B1 and
the bottom panel is mouse anti-GADD 45. The GADD 45 antibody used
(Santa Cruz Biotechnology Inc., Santa Cruz, CA) recognizes both the alpha
and beta subunits of the protein.
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It was necessary to mince each biopsy into small pieces, snap
freeze them in liquid nitrogen, and place the samples in an
ice-slurry throughout processing. Once frozen, the homo-
genizing resulted in an improved yield. The introduction of
exogenous RNases and potential cross contamination were
ever-present concerns. In conjunction with sufficient experi-
ence, we found that the homogenizer can work well but was
problematic for our small biopsy specimens. Even when
finely minced, a portion of the sample remained trapped
within the probe, leading to loss and yield variability. As an
alternative method, beading–beating was performed with
the FastPreps 120 instrument from Q-BIOgene (Irvine, CA).
The samples were processed in RNase and DNase free
Matrix D Lysing tubes supplied by the manufacturer and
no mincing or freezing was required before processing
(Q-BIOgene, Irvine CA). The lysing tubes were filled with
1 mm of the lysis buffer and the sample was added and
processed immediately. Using the FastPreps bead beating,
we were able to reduce sample variability, reduce exposure
to exogenous contamination and process up to 12 samples
very quickly.
The intent of this work is to allow for maximum efficiency
when extracting our molecules of interest. It is necessary to
do this reliably with all biopsy samples, so that consistently
repeatable results are obtained. The process by which
these molecules are extracted must be compatible with
and lead to usable data in downstream techniques. To this
end, we compared the method of bead beading to homo-
genization using quantitative real-time PCR. We were able to
show that our method produces quality RNA suitable for
sensitive downstream RNA applications. The quantitative
real-time PCR data showed that low, medium, and highly
expressed genes can be detected using either method of
disruption (Table 2). The average Ct values for the low,
medium, and high abundance genes are similarly expressed
in each of the samples. This indicates that we should
expect to see similar yields of RNA species between the
two methods.
The total number of biopsies which yield usable informa-
tion from our method is greater than 90%, resulting in a
significant improvement over prior RNA extraction proce-
dures from skin biopsies (Cole et al., 2001b). A high
biopsy yield is necessary for studies involving time course
or dose–response data, as the pre-treatment biopsy serves as
the control for the individual patient. Whole patient data sets
may be rendered useless if the pre-treatment control sample
is lost and for this reason, maximizing the biopsy yield is of
critical importance.
In expression studies, the variability between individual
patient samples can cause a high signal background, which
masks the less abundantly expressed genes that may be
upregulated. This is of particular concern in systems that
utilize complex tissue samples containing multiple cells types
and cell-to-cell contact (Cole et al., 2001a). A statistical
analysis method has recently been developed in conjunction
with our laboratory that solves the problem of high variability
between patients by examining focused gene sets within the
arrays (Rocke et al., 2005).
In summary, with today’s molecular techniques it is
possible to run full-scale genomic and proteomic studies
with microgram quantities of RNA and protein. Care must be
taken to preserve the integrity of the sample during
preparation for these various sensitive studies. We have
developed an optimized extraction method for small
volume human tissue samples which can be easily adopted
in any translational research laboratory. We have used this
method for processing patient punch biopsy samples and
have performed microarray analysis with both the Illumina
and Affymetrix platforms with successful results (Goldberg
et al., 2006). With this method, tandem proteomic and
genomic analysis will allow for potential correlation between
RNA and protein expression data.
MATERIALS AND METHODS
See Supplementary materials.
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